Baxter (BAX) Tops Q4 EPS by 5c, Offers Q1 and FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Baxter Reports 2018 Fourth-Quarter and Full-Year Results
January 31, 2019 7:15 AM ESTFourth-quarter revenue of $2.8 billion increased 2 percent on a reported basis and 5 percent on an operational basis Fourth-quarter GAAP earnings per share (EPS) of $0.66; adjusted EPS of $0.78 increased 22 percent Full-year revenue of $11.1 billion increased 5 percent on a reported basis and 3 percent on an operational basis Full-year GAAP earnings per share were $2.99; adjusted EPS of $3.05 increased 23 percent
DEERFIELD, Ill.--(BUSINESS WIRE)-- Baxter International Inc. (NYSE: BAX), a leading global medical products company, today reported results... More
